Vermillion, Inc.

NASDAQ: VRMLHealthcare / Diagnostic Substances / USA
0.8900-0.1500-14.42%Vol 1 539 6191Y Perf 1.11%
Jun 20th, 2019 16:00
BID0.8900 ASK0.9000
Open1.06 Previous Close1.04
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.25 
Analyst Rating
— 0.00
Potencial %
152.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/33/23 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/-65/64 
Growth Ranking
★★     44.80
Insiders Shares Cnt. % 3/6/12M
100/14/75 
Income Ranking
 —    -
Market Cap (mil)67 
Earnings Rating
Neutral
Price Range Ratio 52wk %
47.69 
Earnings Date
8th Aug 2019

Today's Price Range

0.73001.08

52wk Range

0.27001.57

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-16.80%
3 Months
-22.96%
6 Months
181.08%
1 Year
1.11%
3 Years
-16.13%
5 Years
-60.46%

Name / TickerPriceChg.Chg.%
VRML0.8900-0.1500-14.42
AAPL199.461.59000.80
GOOG1 111.429.09000.82
MSFT136.951.26000.93
XOM76.611.29001.71
WFC45.860.21000.46
JNJ142.211.76001.25
FB189.532.05001.09
GE10.630.29002.80
JPM110.190.28000.25
Earnings HistoryEstimateReportedSurprise %
Q04 2016--0.05-
Q02 2016--0.07-
Q01 2016--0.09-
Q04 2015--0.10-
Q03 2015-0.10-0.100.00
Q02 2015-0.08-0.11-37.50
Q01 2015-0.10-0.100.00
Q04 2014-0.08-0.11-37.50
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date8th Aug 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 539 619
Shares Outstanding (in ths.)75 580
Trades Count1 040
Dollar Volume1 526 562
Avg. Volume144 392
Avg. Weekly Volume348 481
Avg. Monthly Volume138 860
Avg. Quarterly Volume119 953
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0
0 (0.00 %)
0 (0.00 %)
Hold
0
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0
0 (0.00 %)
0 (0.00 %)
Strong Sell
0
0 (0.00 %)
0 (0.00 %)
Rating-Hold
3.00
Hold
3.00

Vermillion, Inc.

Vermillion Inc is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices.

CEO: Valerie Palmieri

Teplephone: +1 512 519-0400

Address: 12117 Bee Caves Road, Building Three, Austin 78738, TX, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

41%59%

Bearish Bullish

46%54%

News